At a glance
ClinicalIndex Comparison RecordN/AActive· 32 enrolled
Drug / intervention
Robotic-Assisted Surgerydevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective, Multi-Center Investigation of the da Vinci SP Surgical System in Pulmonary and Lobectomy for Benign and Malignant Disease
In Brief
A clinical study evaluating Robotic-Assisted Surgery for Primary Lung Cancer and 3 related conditions. Active but no longer recruiting, targeting 32 participants across 6 sites.
Detailed Summary
To confirm the safety and performance of the da Vinci SP Surgical System, Instruments and Accessories in pulmonary lobectomy, and in thymectomy procedures.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPrimary Lung Cancer, Benign Lung Disease, Thymoma, Myasthenia Gravis
CountriesUnited States
Collaborators--
Timeline
N/AActive
2022202320242025202620272028
First PostedDec 2021
Enrollment StartJul 2022
Primary CompletionJun 2023
TodayJul 2026
Study CompletionJul 2028
First PostedDec 9, 2021
Enrollment StartJul 20, 2022
Primary CompletionJun 16, 2023
Study CompletionJul 1, 2028
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 4.6 years ago
Interventions
Robotic-Assisted Surgerydevice
da Vinci SP Surgical System, instruments, and accessories in pulmonary lobectomy and thymectomy for benign and malignant disease.